CORLINE BIOMEDICAL AB |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.05 SEK | -0.50% |
|
-0.50% | -32.55% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 36M 3.36M | Sales 2025 * | 60M 5.6M | Capitalization | 217M 20.25M |
|---|---|---|---|---|---|
| Net income 2024 * | -11M -1.03M | Net income 2025 * | 20M 1.87M | EV / Sales 2024 * | 5.58 x |
| Net cash position 2024 * | 16M 1.49M | Net cash position 2025 * | 30M 2.8M | EV / Sales 2025 * | 3.12 x |
| P/E ratio 2024 * |
-20.2
x | P/E ratio 2025 * |
11.1
x | Employees | 13 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 45.17% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.50% | ||
| 1 week | -0.50% | ||
| Current month | -4.74% | ||
| 1 month | -7.37% | ||
| 3 months | -25.56% | ||
| 6 months | -13.36% | ||
| Current year | -32.55% |
1 week
10.00
11.50
1 month
9.6411.50
Current year
9.6416.80
1 year
9.6418.15
3 years
7.6019.85
5 years
7.6026.60
10 years
6.4031.00
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 07-12-31 | |
Gunnar Tufveson
CTO | Chief Tech/Sci/R&D Officer | - | 17-12-31 |
Fredrik Carlsson
CTO | Chief Tech/Sci/R&D Officer | - | 10-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Magnus Nilsson
BRD | Director/Board Member | 68 | 20-11-17 |
| Director/Board Member | - | 04-12-31 | |
| Chairman | 51 | 04-12-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-22 | 10.05 | -0.50% | 760 |
| 24-05-21 | 10.1 | -3.81% | 20,131 |
| 24-05-20 | 10.5 | 0.00% | 8,158 |
| 24-05-17 | 10.5 | +3.96% | 2,952 |
| 24-05-16 | 10.1 | 0.00% | 9,344 |
Delayed Quote Nasdaq Stockholm, May 22, 2024 at 04:03 am EDT
More quotes
Corline Biomedical AB is a Sweden-based biotechnology company. It develops, manufactures and markets heparin-based solutions to improve kidney transplantation, cell therapies and applications in regenerative medicine.
Sector
Pharmaceuticals
Calendar
2024-08-22
- Q2 2024 Earnings Release
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -32.55% | 20.28M | |
| +15.23% | 78.22B | |
| +8.25% | 8.84B | |
| -12.05% | 5.07B | |
| +53.66% | 4.82B | |
| +11.63% | 4.2B | |
| -23.67% | 2.28B | |
| +10.10% | 2.28B | |
| -32.35% | 2.12B | |
| +21.04% | 2.2B |
- Stock Market
- Equities
- CLBIO Stock
